GGrantIndex
← Leaderboards

Lachlan James Smith

University Of Pennsylvania

$3,508,362
Attributed
$5,716,312
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,716,312 · 6

By mechanism

R01$4,646,520 · 2
R21$792,562 · 2
R03$240,000 · 1
R13$37,230 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsTissuesPhenotypeIn VivoSignal TransductionPostnatalFailureIntervertebral Disk DegenerationIntervertebral Disc StructureBiomechanicsChondrocytesMolecularGrowthClinically RelevantSpine Bone StructureAnimal ModelCell PhysiologyStructureSignal PathwayDoseDrug Delivery SystemsExtracellularCanis FamiliarisBeta-Glucuronidase

Grant awards (21)

Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$500,264
R01 · FY2025 · AR · contact PI
ORS Spine Section Symposia: Enhancing Spine Research throughMentoring, Diversity and Collaboration$12,410
R13 · FY2025 · AR · contact PI
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$546,109
R01 · FY2024 · AR · contact PI
ORS Spine Section Symposia: Enhancing Spine Research throughMentoring, Diversity and Collaboration$12,410
R13 · FY2024 · AR · contact PI
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$537,934
R01 · FY2023 · AR · contact PI
ORS Spine Section Symposia: Enhancing Spine Research throughMentoring, Diversity and Collaboration$12,410
R13 · FY2023 · AR · contact PI
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$545,884
R01 · FY2022 · AR · contact PI
Dynamic heterogeneity of nucleus pulposus cells from development to degeneration$176,963
R21 · FY2022 · AR · contact PI
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$587,313
R01 · FY2021 · AR · contact PI
Pathogenesis and Treatment of Bone Disease in the Mucopolysaccharidoses$344,172
R01 · FY2021 · AR · contact PI
Dynamic heterogeneity of nucleus pulposus cells from development to degeneration$214,390
R21 · FY2021 · AR · contact PI
Pathogenesis and Treatment of Bone Disease in the Mucopolysaccharidoses$354,817
R01 · FY2020 · AR · contact PI
Pathogenesis and Treatment of Bone Disease in the Mucopolysaccharidoses$150,325
R01 · FY2020 · AR · contact PI
Pathogenesis and Treatment of Bone Disease in the Mucopolysaccharidoses$354,817
R01 · FY2019 · AR · contact PI
Pathogenesis and Treatment of Bone Disease in the Mucopolysaccharidoses$361,801
R01 · FY2018 · AR · contact PI
Regenerative potential of embryonic notochordal nucleus pulposus progenitors$181,821
R21 · FY2018 · AR · contact PI
Pathogenesis and Treatment of Bone Disease in the Mucopolysaccharidoses$363,084
R01 · FY2017 · AR · contact PI
Regenerative potential of embryonic notochordal nucleus pulposus progenitors$219,388
R21 · FY2017 · AR · contact PI
Mechanisms of Vertebral Bone Disease in Mucopolysaccharidosis VII$80,000
R03 · FY2016 · AR · contact PI
Mechanisms of Vertebral Bone Disease in Mucopolysaccharidosis VII$80,000
R03 · FY2015 · AR · contact PI
Mechanisms of Vertebral Bone Disease in Mucopolysaccharidosis VII$80,000
R03 · FY2014 · AR · contact PI